C41H40FN9O5 — CID 166117035
5-tert-butyl-N-[[4-[6-[5-[[7-(2,6-dioxopiperidin-3-yl)oxy-1-methyl-3,4-dihydro-1H-isoquinolin-2-yl]methyl]-2-pyridinyl]pyrrolo[2,1-f][1,2,4]triazin-4-yl]-2-fluorophenyl]methyl]-1,2,4-oxadiazole-3-carboxamide (PubChem CID 166117035) has the molecular formula C41H40FN9O5 and a molecular weight of 757.83 g/mol. Its IUPAC name is 5-tert-butyl-N-[[4-[6-[5-[[7-(2,6-dioxopiperidin-3-yl)oxy-1-methyl-3,4-dihydro-1H-isoquinolin-2-yl]methyl]-2-pyridinyl]pyrrolo[2,1-f][1,2,4]triazin-4-yl]-2-fluorophenyl]methyl]-1,2,4-oxadiazole-3-carboxamide.
| Compound Name | 5-tert-butyl-N-[[4-[6-[5-[[7-(2,6-dioxopiperidin-3-yl)oxy-1-methyl-3,4-dihydro-1H-isoquinolin-2-yl]methyl]-2-pyridinyl]pyrrolo[2,1-f][1,2,4]triazin-4-yl]-2-fluorophenyl]methyl]-1,2,4-oxadiazole-3-carboxamide |
|---|---|
| PubChem CID | 166117035 |
| Molecular Formula | C41H40FN9O5 |
| Molecular Weight | 757.83 g/mol |
| Exact Mass | 757.31 |
| IUPAC Name | 5-tert-butyl-N-[[4-[6-[5-[[7-(2,6-dioxopiperidin-3-yl)oxy-1-methyl-3,4-dihydro-1H-isoquinolin-2-yl]methyl]-2-pyridinyl]pyrrolo[2,1-f][1,2,4]triazin-4-yl]-2-fluorophenyl]methyl]-1,2,4-oxadiazole-3-carboxamide |
| SMILES | CC1c2cc(OC3CCC(=O)NC3=O)ccc2CCN1Cc1ccc(-c2cc3c(-c4ccc(CNC(=O)c5noc(C(C)(C)C)n5)c(F)c4)ncnn3c2)nc1 |
| InChI | InChI=1S/C41H40FN9O5/c1-23-30-17-29(55-34-11-12-35(52)47-38(34)53)9-8-25(30)13-14-50(23)20-24-5-10-32(43-18-24)28-16-33-36(45-22-46-51(33)21-28)26-6-7-27(31(42)15-26)19-44-39(54)37-48-40(56-49-37)41(2,3)4/h5-10,15-18,21-23,34H,11-14,19-20H2,1-4H3,(H,44,54)(H,47,52,53) |
| InChIKey | JNHICHCKUJWXGC-UHFFFAOYSA-N |
| XLogP | 5.51 |
| TPSA | 169.74 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 12 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 56 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 757.83 |
| LogP ≤ 5 | 5.51 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 12 |
| Structural Alerts | {'alert_name': 'phthalimide', 'substructure': 'N/A'} |
|---|